SCHEMBL7800028

SCHEMBL7800028

C=C(C)C(=O)Nc1ccc(C(C)=O)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.66
RXFP1 Q9HBX9 1/20 0.62
NPC1 O15118 7/20 0.56
MAPT P10636 7/20 0.56
SMN1; SMN2 Q16637 6/20 0.56
RAB9A P51151 5/20 0.56
TAAR1 Q96RJ0 1/20 0.56
KMT2A Q03164 4/20 0.55
MEN1 O00255 3/20 0.55
HTT P42858 1/20 0.55
NLRP1 Q9C000 1/20 0.55
GAA P10253 2/20 0.51
NFKB1 P19838 1/20 0.51
NFKB2 Q00653 1/20 0.51
RELA Q04206 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
ALDH1A1 P00352 3/20 0.50
MAPK1 P28482 2/20 0.49
TP53 P04637 1/20 0.49
LMNA P02545 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL439393 0.89 RXFP1 (0.74) TDP1RXFP1NPC1MAPTSMN1; SMN2
SCHEMBL17299114 0.88 RXFP1 (0.62) TDP1RXFP1NPC1MAPTSMN1; SMN2
SCHEMBL345555 0.86 RXFP1 (0.61) TDP1RXFP1NPC1MAPTSMN1; SMN2
SCHEMBL24799884 0.85 RXFP1 (0.59) TDP1RXFP1NPC1MAPTSMN1; SMN2
SCHEMBL16866619 0.85 RXFP1 (0.59) TDP1RXFP1NPC1MAPTSMN1; SMN2
SCHEMBL17084525 0.83 RXFP1 (0.67) TDP1RXFP1NPC1MAPTSMN1; SMN2
SCHEMBL529066 0.83 MEN1 (0.61) TDP1RXFP1NPC1MAPTSMN1; SMN2
SCHEMBL13921976 0.82 KMT2A (0.52) TDP1RXFP1MAPTKMT2AMEN1
SCHEMBL2135316 0.82 F2 (0.73) TDP1RXFP1
SCHEMBL13756133 0.82 RXFP1 (0.56) TDP1RXFP1NPC1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114099705-B Nanometer medicine based on hydralazine for improving tumor microenvironment and preparation and application thereof 浙江大学杭州国际科创中心 2023-06-13 CN claimed
CN-114177137-B Immunity activation based guanylated nano-drug and preparation and application thereof 浙江大学杭州国际科创中心 2023-04-14 CN claimed
CN-114177137-A Immunity activation based guanylated nano-drug and preparation and application thereof 浙江大学杭州国际科创中心 2022-03-15 CN claimed
CN-114099705-A Hydralazine-based nano-drug for improving tumor microenvironment, and preparation and application thereof 浙江大学杭州国际科创中心 2022-03-01 CN claimed
CN-114099705-B Nanometer medicine based on hydralazine for improving tumor microenvironment and preparation and application thereof 浙江大学杭州国际科创中心 2023-06-13 CN disclosed
CN-114177137-B Immunity activation based guanylated nano-drug and preparation and application thereof 浙江大学杭州国际科创中心 2023-04-14 CN disclosed
CN-114177137-A Immunity activation based guanylated nano-drug and preparation and application thereof 浙江大学杭州国际科创中心 2022-03-15 CN disclosed
CN-114099705-A Hydralazine-based nano-drug for improving tumor microenvironment, and preparation and application thereof 浙江大学杭州国际科创中心 2022-03-01 CN disclosed
EP-0823661-B1 Composition for anti-reflective coating material FUJI PHOTO FILM CO LTD (JP) 2001-07-04 EP disclosed
US-6248500-B1 ACRYLIC POLYMERS AND PHENOL, NAPHTHOL OR HYDROXYANTHRACENE COMPOUNDS FUJI PHOTO FILM CO., LTD. (JP) 2001-06-19 US disclosed
US-6090531-A UNDERGOES NO INTERMIXING WITH THE RESIST LAYER, PROVIDES AN EXCELLENT RESIST PATTERN AND SHOWS A HIGHER DRY ETCHING RATE THAN RESIST AND A RESIST PATTERN FORMATION PROCESS FUJI PHOTO FILM CO., LTD. (JP) 2000-07-18 US disclosed
EP-0823661-A1 Composition for anti-reflective coating material FUJI PHOTO FILM CO., LTD. (JP) 1998-02-11 EP disclosed